Outcome during 140 months | Surgical | Medical | RBR (95% CI)‡ | NNH (CI)‡ |
---|---|---|---|---|
Survival | 60% | 72% | 20% (0.5 to 33) | 7 (5 to 283) |
Outcomes at mean 10 year | RRR (CI) | NNT (CI) | ||
---|---|---|---|---|
†RBR = relative benefit reduction. Other abbreviations defined in glossary; RBR, RRR, NNH, NNT, and CI calculated from data in article. | ||||
‡Calculated by using Cox proportional-hazards data. | ||||
Any antireflux medication | 62% | 92% | 33% (17 to 50) | 4 (3 to 7) |
Proton pump inhibitor use | 32% | 64% | 49% (21 to 70) | 4 (3 to 9) |
Histamine-2-receptor blocker use | 41% | 65% | 37% (8.7 to 60) | 5 (3 to 20) |